• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Garmin Introduces Its Latest Health-Tracking Smartwatch, the Venu 2

Share:

April 29, 2021

This morning, Garmin rolled out its new Venu 2 Series GPS smartwatch, which has sleep score capability. The Venu 2 gives users specific insights about their sleep, including light, deep, and REM sleep. Users can also view information about their pulse oxygen and respiration rate when sleeping.

The new watch is able to give users their body age by using their chronological age, activity, resting heart rate, and BMI or percent body fat.

In addition, users can see their health records over time with a “health snapshot” function, which logs, records, and shares health statistics. Wearers can also gain insights into their Pulse Ox2, stress rates, and hydration.

The watch has a fitness focus and provides users with more than 25 sports apps. It is listed at $399.

WHY IT MATTERS

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

According to Pew Research Center, 21% of Americans report using a smartwatch or fitness tracker. The report found that adults making over $75,000 a year were the most likely to own a wearable.

Household brands such as Fitbit, Apple, and Amazon have rolled out a slew of consumer-grade wearables. Like Garmin, these companies are pitching the technology as a way to help users boost their fitness and lifestyle.

“At the core of the Venu product line is the belief that when you live healthily, you live better,” Dan Bartel, Garmin vice president of global consumer sales, said in a statement. “The Venu 2 series builds on this story with exciting new features that help explain what’s going on inside your body as well as the fitness and wellness tools needed to make healthy choices every day.”

THE LARGER TRENDS

Garmin consistently rolls out new watches multiple times a year. In 2021 alone, it unveiled its Enduro, a watch designed for athletic training with GPS, and a smaller wearable called Lily, which the company pitched as a product “designed by women, for women.”

However, unlike other wearable companies, Garmin has not yet integrated an ECG into its products. In 2018, Apple changed the wearable game when it announced an atrial fibrillation-detecting algorithm and an ECG for the company’s Series 4 Apple Watch.

Source: Mobihealthnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Charles River Laboratories to Acquire Vigene Biosciences to Enhance Gene Therapy CapabilitiesCharles River Laboratories to Acquire Vigene Biosciences to Enhance Gene Therapy Capabilities
  • SLUCare picks Medial EarlySign’s AI tool to flag patients at risk for lower GI disordersSLUCare picks Medial EarlySign’s AI tool to flag patients at risk for lower GI disorders
  • LHC Group and LifePoint Health Expand Partnership with Acquisition in ArkansasLHC Group and LifePoint Health Expand Partnership with Acquisition in Arkansas
  • Pfizer Acquires Seagen For $43B To Tackle CancerPfizer Acquires Seagen For $43B To Tackle Cancer
  • Antibe builds case for GI safety of naproxen alternativeAntibe builds case for GI safety of naproxen alternative
  • Medtronic Acquires AI-Powered Surgical Simulation Platform Digital SurgeryMedtronic Acquires AI-Powered Surgical Simulation Platform Digital Surgery
  • Avania Acquires IMARC, Global Medical Device CROAvania Acquires IMARC, Global Medical Device CRO
  • Biostem Technologies to Acquire Majority of Assets of Auxocell Laboratories, Inc.Biostem Technologies to Acquire Majority of Assets of Auxocell Laboratories, Inc.

Trending This Week

  • Treehill Partners’ Ali Pashazadeh on How to Improve Clinical Trial Design
  • M&A and investing activity in the Indian healthcare sector has been strong
  • AI-Powered Approach for Personalized Heart Disease Care
  • Clinical Trial Data Strategy: Shifting to Innovative Data Collection and Flow While Reducing Burden On Your Sites
  • AstraZeneca Forms Health Tech Business, Evinova to Deliver Digital Health Solutions for Life Sciences
  • Memorial Hermann Health System, AI-enabled Laudio partner for frontline leaders

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications